Publikasi Scopus FKUI 2021 per tanggal 31 Mei 2021 (358 artikel)

Susanto A.D., Triyoga P.A., Isbaniah F., Fairuz A., Cendikiawan H., Zaron F., Aryanti I., Irbah S.N., Hidayat M.
57190425587;57222896246;36489441300;57222895896;57222896833;57222896488;57222896415;57222896232;56435992700;
Lung fibrosis sequelae after recovery from COVID-19 infection
2021
Journal of Infection in Developing Countries
15
3
360
365
Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia-Persahabatan Hospital, Jakarta, Indonesia; Lung Clinic, Eka Hospital Cibubur, West Java, Indonesia; Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Radiology Departement, Eka Hospital Cibubur, West Java, Indonesia; Faculty of Medicine, University of Mataram, Mataram, West Nusa Tenggara, Indonesia
Susanto, A.D., Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia-Persahabatan Hospital, Jakarta, Indonesia, Lung Clinic, Eka Hospital Cibubur, West Java, Indonesia; Triyoga, P.A., Lung Clinic, Eka Hospital Cibubur, West Java, Indonesia; Isbaniah, F., Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia-Persahabatan Hospital, Jakarta, Indonesia; Fairuz, A., Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Cendikiawan, H., Radiology Departement, Eka Hospital Cibubur, West Java, Indonesia; Zaron, F., Radiology Departement, Eka Hospital Cibubur, West Java, Indonesia; Aryanti, I., Radiology Departement, Eka Hospital Cibubur, West Java, Indonesia; Irbah, S.N., Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Hidayat, M., Faculty of Medicine, University of Mataram, Mataram, West Nusa Tenggara, Indonesia
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that causes coronavirus diseases 2019 (COVID-19). The SARS-CoV-2 is very contagious and nobody is known to be immune to it. The post-infected lung would leave a scar known as fibrosis, a scar tissue. A study from Wuhan, China suggested the development of fibrosis, though it was too early to label these lung changes as irreversible fibrosis in a time range of 3 weeks. The occurrence of fibrosis indicates a chronic infection which greatly contributes to the hallmark symptom of COVID-19 induced ARDS such as shortness of breath and chest pain. However, many of those studies have not yet explained the condition of the patient's lung after total recovery from the COVID-19. This report demonstrates the clinical symptoms, chest CT scan, spirometry, and blood gas analysis of patient after total recovery from the COVID-19 with appearance lung fibrosis. Copyright © 2021 Susanto et al.
COVID-19; Lung fibrosis; Recovery
ascorbic acid plus vitamin B complex; azithromycin; beta 2 adrenergic receptor stimulating agent; chloroquine; corticosteroid; hemoglobin; levofloxacin; meropenem; oseltamivir; adult; adult respiratory distress syndrome; Article; blood gas analysis; breathing rate; case report; cell count; clinical article; computer assisted tomography; coronavirus disease 2019; coughing; dyspnea; fever; forced expiratory volume; forced vital capacity; ground glass opacity; headache; hospitalization; human; lung examination; lung fibrosis; male; middle aged; nose smear; oropharyngeal swab; oxygen saturation; oxygen therapy; physical examination; pneumonia; quality of life; real time polymerase chain reaction; rhinorrhea; Severe acute respiratory syndrome coronavirus 2; spirometry; thorax pain; thorax radio
Journal of Infection in Developing Countries
20366590
33839710
Article
Q3
373
12357